Medicare Program; Meeting of the Medicare Coverage Advisory Committee-August 30, 2006, 36120-36121 [E6-9480]
Download as PDF
36120
Federal Register / Vol. 71, No. 121 / Friday, June 23, 2006 / Notices
Persons wishing to attend this
meeting, which is located on Federal
property, must e-mail the Panel DFO to
register in advance no later than 5 p.m.
(e.d.t.), Wednesday, August 9, 2006. A
confirmation will be sent to the
requester(s) via return e-mail.
The following information must be emailed or telephoned to the DFO by the
date and time above:
• Name(s) of attendee(s),
• Title(s),
• Organization,
• E-mail address(es), and
• Telephone number(s).
VIII. Security, Building, and Parking
Guidelines
IX. Special Accommodations
jlentini on PROD1PC65 with NOTICES
Individuals requiring sign-language
interpretation or other special
accommodations must send a request
for these services to the DFO by 5 p.m.
(e.d.t.), Wednesday, August 9, 2006.
Authority: Section 1833(t)(9) of the Act (42
U.S.C. 13951(t)). The Panel is governed by
the provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare-Hospital
Insurance; and Program No. 93.774,
Medicare-Supplementary Medical Insurance
Program).
17:22 Jun 22, 2006
Jkt 208001
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3170–N]
Medicare Program; Meeting of the
Medicare Coverage Advisory
Committee—August 30, 2006
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
Persons attending the meeting must
present photographic identification to
the Federal Protective Service or Guard
Service personnel before they will be
allowed to enter the building.
Security measures will include
inspection of vehicles, inside and out, at
the entrance to the grounds. In addition,
all persons entering the building must
pass through a metal detector. All items
brought to CMS, including personal
items such as desktops, cell phones,
palm pilots, etc., are subject to physical
inspection.
Individuals who are not registered in
advance will not be permitted to enter
the building and will be unable to
attend the meeting. (Note: Presenters
must also be registered for attendance at
the meeting.) The public may enter the
building 30–45 minutes before the
meeting convenes each day. (The
meeting on Wednesday, August 23,
2006, convenes at 1 p.m.)
All visitors must be escorted in areas
other than the lower and first-floor
levels in the Central Building.
Parking permits and instructions are
issued upon arrival by the guards at the
main entrance.
VerDate Aug<31>2005
Dated: June 16, 2006.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. E6–9905 Filed 6–22–06; 8:45 am]
SUMMARY: This notice announces a
public meeting of the Medicare
Coverage Advisory Committee (MCAC)
(‘‘Committee’’). Among other things, the
Committee provides advice and
recommendations about whether
scientific evidence is adequate to
determine whether certain medical
items and services are reasonable and
necessary under the Medicare statute.
This meeting will discuss the following
issues: (1) Glycemic control and the use
of glucose monitors by which sensors
automatically monitor glucose levels in
body fluids; and (2) whether and how
the frequency of outpatient glucose
monitoring is related to glycemic
control and clinical outcomes in the
various Medicare populations.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)).
DATES: The public meeting will be held
on Wednesday, August 30, 2006 from
7:30 a.m. until 4:30 p.m., e.s.t.
Deadlines: Deadline for Presentations
and Comments: Send written comments
and presentations to the address listed
in the ADDRESSES section of this notice
by 5 p.m., e.s.t. on July 31, 2006. [Please
note that the presentation you submit
will be final, as no further changes to
the presentation can be accepted after
submission.]
Deadline for Meeting Registration: For
security reasons, individuals wishing to
attend this meeting must register by 5
p.m., e.s.t. on August 24, 2006.
Special Accommodations: Persons
attending the meeting who are hearing
or visually impaired, or have a
condition that requires special
assistance or accommodations, are
asked to notify the Executive Secretary
(see FOR FURTHER INFORMATION CONTACT)
by August 24, 2006.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Meeting Location: The
meeting will be held in the main
auditorium of the Centers for Medicare
& Medicaid Services, 7500 Security
Blvd., Baltimore, MD 21244.
Registration: Register by contacting
Maria Ellis (410–786–0309;
Maria.Ellis@cms.hhs.gov; Centers for
Medicare & Medicaid Services, OCSQ—
Coverage and Analysis Group, C1–09–
06, 7500 Security Boulevard, Baltimore,
MD 21244).
Presentation and Comment
Submission: Submit presentation and
comments to Michelle Atkinson,
Centers for Medicare & Medicaid
Services, OCSQ—Coverage and Analysis
Group, C1–09–06, 7500 Security
Boulevard, Baltimore, MD 21244.
Web Site: You may access up-to-date
information on this meeting at https://
www.cms.hhs.gov/FACA/
02_MCAC.asp#TopOfPage.
Presentations And Comments:
Interested persons may present data,
information, or views orally or in
writing on issues pending before the
Committee. Please submit written
comments and presentations to the
Executive Secretary at the address listed
in the ADDRESSES section of this notice.
FOR FURTHER INFORMATION CONTACT:
Michelle Atkinson, Executive Secretary
for MCAC, (410–786–2881;
Michelle.Atkinson@cms.hhs.gov;
Centers for Medicare & Medicaid
Services, OCSQ—Coverage and Analysis
Group, C1–09–06, 7500 Security
Boulevard, Baltimore, MD 21244).
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. Meeting Topic
On December 14, 1998, we published
a notice in the Federal Register (63 FR
68780) to describe the Medicare
Coverage Advisory Committee (MCAC),
which provides advice and
recommendations to CMS about clinical
issues.
This notice announces the August 30,
2006 public meeting of the Committee.
During this meeting, the Committee will
discuss evidence and hear presentations
and public comments concerning
outpatient glycemic control (as
measured by glycated hemoglobin), the
frequency of glucose monitoring, and
clinical outcomes in the Medicare
populations. Specifically, the
Committee will review the available
data on the ability of glycemic control
to blunt the progression of disease,
reverse diabetic complications, and alter
morbidity and mortality in the Medicare
populations; whether the effects of
glycemic control (if any) are linear and
mitigated by increased hypoglycemic
risk; and whether the frequency of
E:\FR\FM\23JNN1.SGM
23JNN1
Federal Register / Vol. 71, No. 121 / Friday, June 23, 2006 / Notices
outpatient glucose monitoring is a
determinant of glycemic control and
clinical outcomes in the Medicare
populations. The role of variables such
as the type of diabetes, the therapeutic
regimen employed, the age of
hyperglycemic onset, the duration of
diabetes, the duration of poor glycemic
control, the level of hyperglycemia, and
concomitant disease will be discussed.
The impediments to glucose monitoring
and use of monitoring data will be
considered. In addition to evaluating the
available data, the Committee will
identify areas in which the current data
are deficient and in which additional
research is warranted.
Background information about this
topic, including panel materials, is
available on the Internet at https://
www.cms.hhs.gov/coverage/.
jlentini on PROD1PC65 with NOTICES
II. Meeting Procedures
This meeting is open to the public.
The Committee will hear oral
presentations from the public for
approximately 45 minutes. The
Committee may limit the number and
duration of oral presentations to the
time available. If you wish to make
formal presentations, you must notify
the Executive Secretary (see FOR
FURTHER INFORMATION CONTACT) and
submit the following to the address
listed in the ADDRESSES section of this
notice by the date listed in the
Deadlines section of this notice: (1) A
brief statement of the general nature of
the evidence or arguments you wish to
present; (2) the names and addresses of
proposed participants; and (3) a written
copy of your presentation. Your
presentation should consider the
questions we have posed to the
Committee and focus on the issues
specific to the topic. The questions will
be available on the following Web site:
https://www.cms.hhs.gov/FACA/
02_MCAC.asp#TopOfPage. We require
that you declare at the meeting whether
you have any financial involvement
with manufacturers of any items or
services being discussed (or with their
competitors).
After the public and CMS
presentations, the Committee will
deliberate openly on the topic.
Interested persons may observe the
deliberations, but the Committee will
not hear further comments during this
time except at the request of the
chairperson. The Committee will also
allow a 15 minute unscheduled open
public session for any attendee to
address issues specific to the topic. At
the conclusion of the day, the members
will vote and the Committee will make
its recommendation.
VerDate Aug<31>2005
17:22 Jun 22, 2006
Jkt 208001
III. Registration Instructions
The Coverage and Analysis Group is
coordinating meeting registration. While
there is no registration fee, individuals
must register to attend. Register by
contacting Maria Ellis at the address
listed in the ADDRESSES section of this
notice. Please provide your name,
address, organization, telephone and fax
numbers, and e-mail address.
You will receive a registration
confirmation with instructions for your
arrival at the CMS complex. You will be
notified if the seating capacity has been
reached.
This meeting is located on Federal
property; therefore, for security reasons,
any individuals wishing to attend this
meeting must register by 5 p.m. e.s.t. on
August 24, 2006.
IV. Security, Building, and Parking
Guidelines
This meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. In
planning your arrival time, we
recommend allowing additional time to
clear security.
In order to gain access to the building
and grounds, individuals must present
photographic identification to the
Federal Protective Service or Guard
Service personnel before being allowed
entrance.
Security measures also include
inspection of vehicles, inside and out, at
the entrance to the grounds. In addition,
all individuals entering the building
must pass through a metal detector. All
items brought to CMS, whether personal
or for the purpose of demonstration or
to support a demonstration, are subject
to inspection. We cannot assume
responsibility for coordinating the
receipt, transfer, transport, storage, setup, safety, or timely arrival of any
personal belongings or items used for
demonstration or to support a
demonstration.
Parking permits and instructions will
be issued upon arrival.
Note: Individuals who are not registered in
advance will not be permitted to enter the
building and will be unable to attend the
meeting. The public may not enter the
building earlier than 30 to 45 minutes prior
to the convening of the meeting.
All visitors must be escorted in areas
other than the lower and first floor
levels in the Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance
Program No. 93.774, Medicare—
Supplementary Medical Insurance Program)
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
36121
Dated: June 7, 2006.
Barry M. Straube,
Chief Medical Officer and Director, Office
of Clinical Standards and Quality, Centers
for Medicare & Medicaid Services.
[FR Doc. E6–9480 Filed 6–22–06; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2004N–0226]
Food and Drug Administration
Modernization Act of 1997:
Modifications to the List of Recognized
Standards, Recognition List Number:
015
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
publication containing modifications
the agency is making to the list of
standards FDA recognizes for use in
premarket reviews (FDA recognized
consensus standards). This publication,
entitled ‘‘Modifications to the List of
Recognized Standards, Recognition List
Number: 015’’ (Recognition List
Number: 015), will assist manufacturers
who elect to declare conformity with
consensus standards to meet certain
requirements for medical devices.
DATES: Submit written or electronic
comments concerning this document at
any time. See section VII of this
document for the effective date of the
recognition of standards announced in
this document.
ADDRESSES: Submit written requests for
single copies of ‘‘Modifications to the
List of Recognized Standards,
Recognition List Number: 015’’ to the
Division of Small Manufacturers,
International and Consumer Assistance,
Center for Devices and Radiological
Health (HFZ–220), Food and Drug
Administration, 1350 Piccard Dr.,
Rockville, MD 20850. Send two selfaddressed adhesive labels to assist that
office in processing your requests, or fax
your request to 301–443–8818. Submit
written comments concerning this
document, or recommendations for
additional standards for recognition, to
the contact person (see FOR FURTHER
INFORMATION CONTACT). Submit
electronic comments by e-mail:
standards@cdrh.fda.gov. This document
may also be accessed on FDA’s Internet
site at https://www.fda.gov/cdrh/
fedregin.html. See section VI of this
document for electronic access to the
E:\FR\FM\23JNN1.SGM
23JNN1
Agencies
[Federal Register Volume 71, Number 121 (Friday, June 23, 2006)]
[Notices]
[Pages 36120-36121]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9480]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3170-N]
Medicare Program; Meeting of the Medicare Coverage Advisory
Committee--August 30, 2006
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting of the Medicare
Coverage Advisory Committee (MCAC) (``Committee''). Among other things,
the Committee provides advice and recommendations about whether
scientific evidence is adequate to determine whether certain medical
items and services are reasonable and necessary under the Medicare
statute. This meeting will discuss the following issues: (1) Glycemic
control and the use of glucose monitors by which sensors automatically
monitor glucose levels in body fluids; and (2) whether and how the
frequency of outpatient glucose monitoring is related to glycemic
control and clinical outcomes in the various Medicare populations.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. App. 2, section 10(a)).
DATES: The public meeting will be held on Wednesday, August 30, 2006
from 7:30 a.m. until 4:30 p.m., e.s.t.
Deadlines: Deadline for Presentations and Comments: Send written
comments and presentations to the address listed in the ADDRESSES
section of this notice by 5 p.m., e.s.t. on July 31, 2006. [Please note
that the presentation you submit will be final, as no further changes
to the presentation can be accepted after submission.]
Deadline for Meeting Registration: For security reasons,
individuals wishing to attend this meeting must register by 5 p.m.,
e.s.t. on August 24, 2006.
Special Accommodations: Persons attending the meeting who are
hearing or visually impaired, or have a condition that requires special
assistance or accommodations, are asked to notify the Executive
Secretary (see FOR FURTHER INFORMATION CONTACT) by August 24, 2006.
ADDRESSES: Meeting Location: The meeting will be held in the main
auditorium of the Centers for Medicare & Medicaid Services, 7500
Security Blvd., Baltimore, MD 21244.
Registration: Register by contacting Maria Ellis (410-786-0309;
Maria.Ellis@cms.hhs.gov; Centers for Medicare & Medicaid Services,
OCSQ--Coverage and Analysis Group, C1-09-06, 7500 Security Boulevard,
Baltimore, MD 21244).
Presentation and Comment Submission: Submit presentation and
comments to Michelle Atkinson, Centers for Medicare & Medicaid
Services, OCSQ--Coverage and Analysis Group, C1-09-06, 7500 Security
Boulevard, Baltimore, MD 21244.
Web Site: You may access up-to-date information on this meeting at
https://www.cms.hhs.gov/FACA/02_MCAC.asp#TopOfPage.
Presentations And Comments: Interested persons may present data,
information, or views orally or in writing on issues pending before the
Committee. Please submit written comments and presentations to the
Executive Secretary at the address listed in the ADDRESSES section of
this notice.
FOR FURTHER INFORMATION CONTACT: Michelle Atkinson, Executive Secretary
for MCAC, (410-786-2881; Michelle.Atkinson@cms.hhs.gov; Centers for
Medicare & Medicaid Services, OCSQ--Coverage and Analysis Group, C1-09-
06, 7500 Security Boulevard, Baltimore, MD 21244).
SUPPLEMENTARY INFORMATION:
I. Meeting Topic
On December 14, 1998, we published a notice in the Federal Register
(63 FR 68780) to describe the Medicare Coverage Advisory Committee
(MCAC), which provides advice and recommendations to CMS about clinical
issues.
This notice announces the August 30, 2006 public meeting of the
Committee. During this meeting, the Committee will discuss evidence and
hear presentations and public comments concerning outpatient glycemic
control (as measured by glycated hemoglobin), the frequency of glucose
monitoring, and clinical outcomes in the Medicare populations.
Specifically, the Committee will review the available data on the
ability of glycemic control to blunt the progression of disease,
reverse diabetic complications, and alter morbidity and mortality in
the Medicare populations; whether the effects of glycemic control (if
any) are linear and mitigated by increased hypoglycemic risk; and
whether the frequency of
[[Page 36121]]
outpatient glucose monitoring is a determinant of glycemic control and
clinical outcomes in the Medicare populations. The role of variables
such as the type of diabetes, the therapeutic regimen employed, the age
of hyperglycemic onset, the duration of diabetes, the duration of poor
glycemic control, the level of hyperglycemia, and concomitant disease
will be discussed. The impediments to glucose monitoring and use of
monitoring data will be considered. In addition to evaluating the
available data, the Committee will identify areas in which the current
data are deficient and in which additional research is warranted.
Background information about this topic, including panel materials,
is available on the Internet at https://www.cms.hhs.gov/coverage/.
II. Meeting Procedures
This meeting is open to the public. The Committee will hear oral
presentations from the public for approximately 45 minutes. The
Committee may limit the number and duration of oral presentations to
the time available. If you wish to make formal presentations, you must
notify the Executive Secretary (see FOR FURTHER INFORMATION CONTACT)
and submit the following to the address listed in the ADDRESSES section
of this notice by the date listed in the Deadlines section of this
notice: (1) A brief statement of the general nature of the evidence or
arguments you wish to present; (2) the names and addresses of proposed
participants; and (3) a written copy of your presentation. Your
presentation should consider the questions we have posed to the
Committee and focus on the issues specific to the topic. The questions
will be available on the following Web site: https://www.cms.hhs.gov/
FACA/02_MCAC.asp#TopOfPage. We require that you declare at the meeting
whether you have any financial involvement with manufacturers of any
items or services being discussed (or with their competitors).
After the public and CMS presentations, the Committee will
deliberate openly on the topic. Interested persons may observe the
deliberations, but the Committee will not hear further comments during
this time except at the request of the chairperson. The Committee will
also allow a 15 minute unscheduled open public session for any attendee
to address issues specific to the topic. At the conclusion of the day,
the members will vote and the Committee will make its recommendation.
III. Registration Instructions
The Coverage and Analysis Group is coordinating meeting
registration. While there is no registration fee, individuals must
register to attend. Register by contacting Maria Ellis at the address
listed in the ADDRESSES section of this notice. Please provide your
name, address, organization, telephone and fax numbers, and e-mail
address.
You will receive a registration confirmation with instructions for
your arrival at the CMS complex. You will be notified if the seating
capacity has been reached.
This meeting is located on Federal property; therefore, for
security reasons, any individuals wishing to attend this meeting must
register by 5 p.m. e.s.t. on August 24, 2006.
IV. Security, Building, and Parking Guidelines
This meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. In planning your
arrival time, we recommend allowing additional time to clear security.
In order to gain access to the building and grounds, individuals
must present photographic identification to the Federal Protective
Service or Guard Service personnel before being allowed entrance.
Security measures also include inspection of vehicles, inside and
out, at the entrance to the grounds. In addition, all individuals
entering the building must pass through a metal detector. All items
brought to CMS, whether personal or for the purpose of demonstration or
to support a demonstration, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set-up, safety, or timely arrival of any personal belongings
or items used for demonstration or to support a demonstration.
Parking permits and instructions will be issued upon arrival.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting. The public may not enter the building earlier than 30 to 45
minutes prior to the convening of the meeting.
All visitors must be escorted in areas other than the lower and
first floor levels in the Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
(Catalog of Federal Domestic Assistance Program No. 93.774,
Medicare--Supplementary Medical Insurance Program)
Dated: June 7, 2006.
Barry M. Straube,
Chief Medical Officer and Director, Office of Clinical Standards and
Quality, Centers for Medicare & Medicaid Services.
[FR Doc. E6-9480 Filed 6-22-06; 8:45 am]
BILLING CODE 4120-01-P